- Dolutegravir 50mg / Rilpivirine 25mg tablets
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Dolutegravir 50mg / Rilpivirine 25mg tablets | Start Date 04-06-2018 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- Other
Codes
- ATC Code
- J05AR21
- BNF Codes
-
- BNF code 05030100
Code | Start Date | End Date |
---|---|---|
35574411000001109 | 04-06-2018 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Dolutegravir sodium | Based on Base Substance | Dolutegravir | 50 mg | |
Rilpivirine hydrochloride | Based on Base Substance | Rilpivirine | 25 mg |
Name
Rilpivirine hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Rilpivirine
Strength and UOM (Nmr)
25
Strength and UOM (Dmr)
Name
Dolutegravir sodium
Basis of strength description
Based on Base Substance
BOSS
Dolutegravir
Strength and UOM (Nmr)
50
Strength and UOM (Dmr)
Parent Products
-
VTMDolutegravir + Rilpivirine
-
VMP(Current) Dolutegravir 50mg / Rilpivirine 25mg...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
30 tablet |